Phibro Animal Health (PAHC) Enterprise Value (2013 - 2026)

Phibro Animal Health's Enterprise Value history runs 14 years deep, the most recent figure standing at -$77.5 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 10.09% year-over-year to -$77.5 million; the TTM figure through Mar 2026 stood at -$77.5 million (down 10.09% YoY), while the FY2025 annual figure was -$77.0 million, up 32.78% from the prior year.
• Enterprise Value was -$77.5 million for Q1 2026 at Phibro Animal Health, down from -$74.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$67.1 million in Q4 2024 to a low of -$114.6 million in Q2 2024.
• Historically, Enterprise Value has averaged -$84.6 million across 5 years, with a median of -$85.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 41.01% in 2024, then surged 32.78% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$78.4 million in 2022, then declined by 17.94% to -$92.5 million in 2023, then gained by 27.48% to -$67.1 million in 2024, then decreased by 11.08% to -$74.5 million in 2025, then fell by 3.95% to -$77.5 million in 2026.
• The last three Enterprise Value figures came in at -$77.5 million (Q1 2026), -$74.5 million (Q4 2025), and -$85.3 million (Q3 2025), per Business Quant data.